×

Stereotaxis to Report Second Quarter 2016 Financial Results on August 9, 2016

ST. LOUIS, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2016 second quarter ended June 30, 2016 on Tuesday, August 9, 2016 after the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the Company’s results and corporate developments.

What:Stereotaxis second quarter 2016 financial results conference call
When:Tuesday, August 9th at 4:30 p.m. Eastern Time (1:30 p.m. PT)
Dial In Number:To access the live call, dial 800-381-2652 (US and Canada) or 719-457-2619 (International) and give the participant pass code 8079214.
Webcast:To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at www.stereotaxis.com
Call Replay:A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through Tuesday, August 16, 2016. To access the replay dial-in information, please click here.

About Stereotaxis

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch® Solution includes the Niobe® ES remote magnetic navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems, and the Vdrive® robotic navigation system and consumables.

The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Canada, China, Japan, and elsewhere. The V-Sono ICE catheter manipulator, V-Loop variable loop catheter manipulator, and V-CAS catheter advancement system have received clearance in the United States, Canada, and the European Union. The V-CAS Deflect catheter advancement system is available for use in the European Union. For more information, please visit www.stereotaxis.com.


Press Contact: Martin Stammer Chief Financial Officer 314-678-6155 Investor Contact: Todd Kehrli / Jim Byers MKR Group, Inc. 323-468-2300 stxs@mkr-group.com

Source:Stereotaxis, Inc.